Mark A. Kay
Director/Board Member at Genevant Sciences Corp.
Mark A. Kay active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Stanford University School of Medicine | Corporate Officer/Principal | 1997-12-31 | - |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Director/Board Member | 2018-11-18 | - |
| Independent Dir/Board Member | 2018-11-18 | - |
Career history of Mark A. Kay
Former positions of Mark A. Kay
| Companies | Position | Start | End |
|---|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Director/Board Member | 2015-12-31 | 2022-11-15 |
| Founder | 2014-07-31 | 2022-11-15 | |
| Independent Dir/Board Member | 2015-12-31 | 2022-11-15 | |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Founder | 2004-12-31 | 2005-12-31 |
| President | 2004-12-31 | 2005-12-31 | |
| VOYAGER THERAPEUTICS, INC. | Founder | 2013-05-31 | - |
Training of Mark A. Kay
| Michigan State University | Undergraduate Degree |
| Case Western Reserve University | Doctorate Degree |
Statistics
International
| United States | 7 |
| Canada | 2 |
Operational
| Founder | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
- Stock Market
- Insiders
- Mark A. Kay
- Experience
